Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
7.42 USD | -0.67% | -4.84% | +9.26% |
04:16pm | Trending : Fulcrum Therapeutics, Sanofi in Losmapimod Licensing Deal | DJ |
03:03pm | Fulcrum Therapeutics, Sanofi Sign Licensing Deal for Facioscapulohumeral Muscular Dystrophy Treatment | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.26% | 464M | |
+26.42% | 44.96B | |
-0.83% | 42.65B | |
+46.00% | 41.85B | |
-5.31% | 29.04B | |
+9.39% | 26.08B | |
-21.21% | 19.03B | |
+5.87% | 12.75B | |
+28.46% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- FULC Stock
- News Fulcrum Therapeutics, Inc.
- Fulcrum Therapeutics Appoints Santiago Arroyo as Chief Medical Officer, Jeff Jacobs as Chief Scientific Officer